查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2088250

醫療保健領域人工智慧（AI）市場：按類型、交付管道、疾病類別、應用、部署模式和最終用戶分類——2026-2032年全球市場預測

Artificial Intelligence in Healthcare Market by Type, Delivery Channel, Disease Category, Application, Deployment Mode, End-User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 187 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，醫療領域的人工智慧 (AI) 市場將成長至 569.6 億美元，複合年成長率為 18.84%。

主要市場統計數據
基準年 2025 170.1億美元
預計年份：2026年 199.8億美元
預測年份 2032 569.6億美元
複合年成長率 (%) 18.84%

醫療領域人工智慧執行摘要

人工智慧在醫療領域的應用正從實驗性試點計畫轉向企業級的臨床、營運和研究基礎設施。推動其普及的因素包括：醫療保健需求不斷成長、勞動力短缺、電子健康記錄的廣泛應用，以及在醫院、保險公司、生命科學公司和整個公共衛生系統範圍內，在控制成本的同時提高治療效果的迫切需求。

醫療人工智慧領域的變革

多模態模型、雲端分析、可互通的資料平台以及直接整合到臨床工作流程中的自動化技術正在改變醫療人工智慧領域。其應用場景正從診斷影像和分診擴展到環境記錄、決策支援、病人參與、收入週期管理、藥物研發、臨床試驗最佳化和醫院容量規劃等領域。

人工智慧在醫療領域的累積影響

人工智慧的累積效應只有在融入整個病人歷程而非作為獨立工具部署時才能發揮最大作用。基於實證醫學的部署能夠提高影像分析速度、減輕管理負擔、增強人群健康分析並支持臨床記錄的創建，結合檢驗的臨床工作流程，可實現早期風險識別。

全球醫療人工智慧市場的關鍵區域洞察

北美憑藉其先進的數位醫療基礎設施、廣泛應用的電子健康記錄(EHR)、完善的 FDA醫療設備認證流程、保險公司分析以及強大的臨床研究生態系統，仍然是醫療人工智慧商業化的領先地區。在歐洲，監管採納也在穩步推進，歐盟人工智慧立法主導對高風險醫療人工智慧的要求，而 GDPR 則繼續影響著互聯醫療、生物醫學研究和跨境健康數據舉措中的「隱私設計」實踐。

關於醫療人工智慧實施的關鍵群體特定見解

東協地區醫療保健領域人工智慧的應用主要受以下因素驅動：對數位醫療、遠端醫療、國家衛生系統現代化以及擴充性醫療服務的需求不斷成長，但數據碎片化、基礎設施不平衡和人力資源準備不足仍然是阻礙因素。在海灣合作理事會（GCC）國家，由人工智慧驅動的醫院、人口健康分析和數位公共衛生平台的應用正藉由國家願景、高額醫療支出和集中式轉型計畫加速推進。

主要國家對人工智慧在醫療領域的應用見解

美國仍然是醫療人工智慧領域的領先創新中心，這得益於FDA的批准、電子健康記錄（EHR）的廣泛應用、學術醫療中心、保險公司的分析以及成熟的數位健康生態系統。加拿大則專注於負責任的人工智慧、公共衛生系統的效率、隱私和臨床檢驗，而墨西哥和巴西正在擴展遠端醫療、診斷和營運分析，以彌合醫療服務取得方面的差距，並改善龐大且多元化人群之間的醫療保健協作。

為醫療人工智慧領導者提供的實用建議

行業領導者應優先投資於能夠解決可衡量的臨床或營運問題的醫療人工智慧。高價值領域包括輔助影像工作流程、自動化文件處理、病患風險分層、供應鏈需求預測、保險理賠分析、病人參與、臨床試驗資訊收集、藥物研發支援。每項舉措都應包含基準指標、臨床醫師工作流程圖、安全要求以及明確的績效指標。

醫療人工智慧市場洞察的調查方法

本執行摘要基於來自檢驗的公共和機構資訊來源的二手資訊來源，包括監管資料庫、醫療保健支出統計數據、國家數位健康策略、同行評審文獻以及來自 FDA、世衛組織、經合組織和歐洲機構等組織的政策框架。

結論：負責任的人工智慧將決定醫療保健的未來。

人工智慧正成為現代醫療保健的基石，它將臨床洞察、營運效率、加速研究和患者參與緊密聯繫起來。當人工智慧得到檢驗、互通性、安全可靠、可解釋性強，並與臨床醫生的決策保持一致時，它將迎來最大的發展機會。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席體驗長觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 市場動態
  • 波特五力分析
  • PESTLE分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：人工智慧的累積影響，2026年

第7章：醫療領域的人工智慧（AI）市場：按類型分類

  • 硬體
    • 監控設備
    • 機器人技術
    • 穿戴式裝置
  • 服務
    • 諮詢服務
    • 實施和整合服務
    • 維護和支援
  • 軟體
    • 臨床決策支援系統
    • 數據管理與分析
    • 藥物發現平台
    • 醫學影像診斷平台
    • 自然語言處理應用

第8章：醫療保健領域的人工智慧（AI）市場：按交付管道分類

  • 數位平台
  • 現場服務
  • 遠端服務

第9章：醫療保健領域的人工智慧（AI）市場：按疾病類別分類

  • 心血管疾病
  • 皮膚病
  • 消化系統疾病
  • 神經系統疾病
  • 腫瘤疾病
  • 整形外科疾病
  • 呼吸系統疾病

第10章：醫療領域的人工智慧（AI）市場：按應用領域分類

  • 管理工作流程
    • 預約管理
    • 帳單管理
    • 合規管理
    • 記錄管理
  • 診斷
    • 臨床試驗
    • 基因檢測
    • 病理診斷
    • 放射診斷
  • 病患監測
    • 重症加護病房監測
    • 遠端患者監護
    • 生命徵象監測
  • 治療管理
    • 藥物治療最佳化
    • 個人化醫療
    • 放射線治療
    • 機器人手術

第11章：醫療領域的人工智慧（AI）市場：以部署方式分類

  • 基於雲端的
  • 混合
  • 現場

第12章：醫療保健產業的人工智慧（AI）市場：按最終用戶分類

  • 學術和研究機構
  • 診斷中心
  • 醫院和醫療保健機構
  • 製藥和生物技術公司

第13章：醫療保健領域的人工智慧（AI）市場：按地區分類

  • 亞太地區
  • 北美洲
  • 拉丁美洲
  • 歐洲
  • 中東
  • 非洲

第14章：醫療保健產業的人工智慧（AI）市場：按群體分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第15章：醫療保健領域的人工智慧（AI）市場：按國家/地區分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第16章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年

第17章：公司簡介

  • AiCure, LLC
  • Aidoc Medical Ltd.
  • Amazon Web Services, Inc.
  • Atomwise Inc.
  • Behold.ai Technologies Limited
  • BenevolentAI Limited
  • BPGbio, Inc.
  • Butterfly Network, Inc.
  • CANON MEDICAL SYSTEMS CORPORATION
  • ClosedLoop.ai Inc.
  • Cognizant Technology Solutions Corporation
  • ConcertAI by SymphonyAI LLC
  • eMed Healthcare UK Limited
  • Epic Systems Corporation
  • Flatiron Health, Inc. by F. Hoffmann-La Roche Ltd.
  • GE Healthcare
  • Google, LLC by Alphabet, Inc.
  • Health Catalyst, Inc.
  • Intel Corporation
  • International Business Machines Corporation
  • IQVIA Holdings Inc.
  • Koninklijke Philips NV
  • Medasense Biometrics Ltd.
  • Medtronic plc
  • Merative LP
  • Microsoft Corporation
  • Modernizing Medicine, Inc.
  • Nano-X Imaging Ltd.
  • Novo Nordisk A/S
  • NVIDIA Corporation
  • Oncora Medical
  • Oracle Corporation
  • Oxipit
  • Palantir Technologies Inc.
  • Recursion Pharmaceuticals, Inc.
  • Salesforce, Inc.
  • Sanofi SA
  • SAS Institute Inc.
  • Sensely, Inc. by Mediktor
  • Siemens Healthineers AG
  • Tempus Labs, Inc.
  • UnitedHealth Group
Product Code: MRR-031BF22F9550

The Artificial Intelligence in Healthcare Market is projected to grow by USD 56.96 billion at a CAGR of 18.84% by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 17.01 billion
Estimated Year [2026] USD 19.98 billion
Forecast Year [2032] USD 56.96 billion
CAGR (%) 18.84%

Artificial Intelligence in Healthcare Executive Summary

Artificial intelligence in healthcare has shifted from experimental pilots to enterprise-scale clinical, operational, and research infrastructure. Adoption is being driven by rising care demand, workforce shortages, expanding electronic health records, and the need to improve outcomes while controlling costs across hospitals, payers, life sciences organizations, and public health systems.

Verified indicators show the healthcare AI landscape is maturing. The U.S. FDA listed more than 950 authorized AI/ML-enabled medical devices in 2024, while WHO data places global health spending above USD 9 trillion annually. OECD and national digital health programs also show continued investment in data infrastructure, interoperability, and digitally enabled care, confirming that healthcare AI is becoming a strategic capability rather than a discretionary technology investment.

Transformative Shifts in the Healthcare AI Landscape

The healthcare AI landscape is being reshaped by multimodal models, cloud-based analytics, interoperable data platforms, and automation embedded directly into clinical workflows. Use cases are expanding from imaging and triage into ambient documentation, decision support, patient engagement, revenue cycle management, drug discovery, clinical trial optimization, and hospital capacity planning.

Regulation is also changing adoption requirements. The EU AI Act classifies many medical AI applications as high-risk, FDA policy continues to address AI/ML-enabled medical devices, HIPAA obligations govern protected health information in the United States, and emerging national AI safety frameworks are pushing organizations toward explainability, model monitoring, cybersecurity, auditability, and human oversight as core requirements for scalable deployment.

Cumulative Impact of Artificial Intelligence in Healthcare

The cumulative impact of artificial intelligence is strongest when AI is integrated across the patient journey rather than deployed as isolated tools. Evidence-backed implementations are improving image analysis speed, reducing administrative burden, strengthening population health analytics, supporting clinical documentation, and enabling earlier detection of risk when paired with validated clinical workflows.

However, impact depends on data quality, governance, model validation, and clinician trust. Bias, privacy exposure, alert fatigue, cybersecurity vulnerabilities, and poor integration can limit value. Industry leaders are therefore prioritizing responsible AI, measurable outcomes, lifecycle monitoring, and transparent performance evaluation to convert innovation into durable healthcare performance gains.

Key Regional Insights Across Global Healthcare AI Markets

North America remains a leading region for healthcare AI commercialization due to advanced digital health infrastructure, widespread EHR use, established FDA medical device pathways, payer analytics, and strong clinical research ecosystems. Europe is advancing through regulated adoption, with the EU AI Act strengthening requirements for high-risk medical AI while GDPR continues to shape privacy-by-design practices across connected care, biomedical research, and cross-border health data initiatives.

Asia-Pacific is scaling healthcare AI through national digital health strategies in China, India, Japan, South Korea, Australia, and ASEAN economies, with applications spanning diagnostics, hospital automation, telehealth, and aging-care support. Latin America is using AI to expand access, improve triage, and support resource allocation across public and private systems, while the Middle East is investing through smart hospital programs, national health transformation plans, and centralized digital infrastructure. Africa shows long-term potential in mobile health, diagnostics, disease surveillance, and public health analytics, particularly where infrastructure investment, connectivity, and data partnerships can help close access gaps.

Key Group Insights for Healthcare AI Adoption

ASEAN healthcare AI adoption is supported by digital health access, telemedicine, national health modernization, and rising demand for scalable care delivery, although data fragmentation, infrastructure variation, and workforce readiness remain constraints. The GCC is accelerating AI-enabled hospitals, population health analytics, and digital public health platforms through national visions, high health expenditure, and centralized transformation programs.

The European Union is shaping global healthcare AI compliance through the EU AI Act, GDPR, the European Health Data Space, and cross-border research initiatives that emphasize trustworthy data use. BRICS economies are scaling AI for access, diagnostics, local innovation, and public health capacity, while G7 markets lead in regulation, reimbursement experimentation, advanced research, and responsible AI governance. NATO members increasingly view health data security, biosecurity, emergency preparedness, and resilient medical systems as strategic priorities, reinforcing the role of secure AI-enabled healthcare infrastructure.

Key Country Insights in Artificial Intelligence for Healthcare

The United States remains a major innovation hub for AI in healthcare, supported by FDA authorizations, EHR penetration, academic medical centers, payer analytics, and a mature digital health ecosystem. Canada emphasizes responsible AI, public health system efficiency, privacy, and clinical validation, while Mexico and Brazil are expanding telehealth, diagnostics, and operational analytics to address access gaps and improve care coordination across large and diverse populations.

In Europe, the United Kingdom, Germany, France, Italy, and Spain are advancing healthcare AI through national health data programs, hospital modernization, medical imaging adoption, and EU-aligned governance, while Russia retains capabilities in medical imaging and research AI despite geopolitical and data-access constraints. China is scaling AI diagnostics, hospital automation, and digital health platforms; India is using AI to extend care access, strengthen public health programs, and support diagnostics; Japan is applying AI to aging population needs and clinical workflow efficiency; Australia is focused on regulated digital health, interoperability, and privacy safeguards; and South Korea is strong in AI medical devices, connected hospitals, and digitally enabled care delivery.

Actionable Recommendations for Healthcare AI Leaders

Industry leaders should prioritize healthcare AI investments that solve measurable clinical or operational problems. High-value areas include imaging workflow support, documentation automation, patient risk stratification, supply chain forecasting, claims analytics, patient engagement, clinical trial intelligence, and drug development support. Each initiative should include baseline metrics, clinician workflow mapping, safety requirements, and defined performance indicators.

Organizations should also establish enterprise AI governance covering data provenance, privacy, cybersecurity, bias testing, model validation, human oversight, and post-deployment monitoring. Partnerships with technology providers, academic centers, health systems, and regulators can accelerate adoption, but ownership of clinical accountability, interoperability, patient consent, and trust must remain central to every healthcare AI strategy.

Research Methodology for Healthcare AI Market Insights

This executive summary is based on secondary research from verified public and institutional sources, including regulatory databases, health expenditure statistics, national digital health strategies, peer-reviewed literature, and policy frameworks from organizations such as the FDA, WHO, OECD, and European institutions.

The methodology triangulates regulatory signals, adoption patterns, regional policy direction, infrastructure readiness, and use-case maturity to identify practical market implications. Claims are limited to evidence-supported trends, and forward-looking insights are framed around observable investment, regulation, interoperability, data governance, and healthcare delivery dynamics.

Conclusion: Responsible AI Defines the Future of Healthcare

Artificial intelligence is becoming a foundational layer of modern healthcare, connecting clinical intelligence, operational efficiency, research acceleration, and patient engagement. The strongest opportunities will emerge where AI is validated, interoperable, secure, explainable, and aligned with clinician decision-making.

As regulation matures and adoption scales, competitive advantage will depend on trusted data ecosystems, measurable outcomes, lifecycle governance, and responsible deployment. Healthcare organizations that combine innovation with governance will be best positioned to improve access, quality, efficiency, safety, and resilience across global health systems.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Market Dynamics
    • 4.3.1. Key Drivers
    • 4.3.2. Key Restraints
    • 4.3.3. Key Opportunities
    • 4.3.4. Key Challenges
  • 4.4. Porter's Five Forces Analysis
  • 4.5. PESTLE Analysis
  • 4.6. Market Outlook
    • 4.6.1. Near-Term Market Outlook (0-2 Years)
    • 4.6.2. Medium-Term Market Outlook (3-5 Years)
    • 4.6.3. Long-Term Market Outlook (5-10 Years)
  • 4.7. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Artificial Intelligence in Healthcare Market, by Type

  • 7.1. Hardware
    • 7.1.1. Monitoring Equipment
    • 7.1.2. Robotics
    • 7.1.3. Wearable Devices
  • 7.2. Services
    • 7.2.1. Consulting Services
    • 7.2.2. Deployment & Integration Services
    • 7.2.3. Maintenance & Support
  • 7.3. Software
    • 7.3.1. Clinical Decision Support Systems
    • 7.3.2. Data Management & Analysis
    • 7.3.3. Drug Discovery Platforms
    • 7.3.4. Medical Imaging Platforms
    • 7.3.5. Natural Language Processing Applications

8. Artificial Intelligence in Healthcare Market, by Delivery Channel

  • 8.1. Digital Platforms
  • 8.2. Onsite Services
  • 8.3. Remote Services

9. Artificial Intelligence in Healthcare Market, by Disease Category

  • 9.1. Cardiovascular Disorders
  • 9.2. Dermatological Disorders
  • 9.3. Gastrointestinal Disorders
  • 9.4. Neurological Disorders
  • 9.5. Oncology Disorders
  • 9.6. Orthopedic Disorders
  • 9.7. Respiratory Disorders

10. Artificial Intelligence in Healthcare Market, by Application

  • 10.1. Administrative Workflow
    • 10.1.1. Appointment Scheduling
    • 10.1.2. Billing Management
    • 10.1.3. Compliance Management
    • 10.1.4. Record Management
  • 10.2. Diagnostics
    • 10.2.1. Clinical Testing
    • 10.2.2. Genetic Testing
    • 10.2.3. Pathology Diagnostics
    • 10.2.4. Radiology Diagnostics
  • 10.3. Patient Monitoring
    • 10.3.1. ICU Monitoring
    • 10.3.2. Remote Patient Monitoring
    • 10.3.3. Vital Sign Monitoring
  • 10.4. Treatment Management
    • 10.4.1. Drug Therapy Optimization
    • 10.4.2. Personalized Medicine
    • 10.4.3. Radiation Therapy
    • 10.4.4. Robotic Surgery

11. Artificial Intelligence in Healthcare Market, by Deployment Mode

  • 11.1. Cloud-Based
  • 11.2. Hybrid
  • 11.3. On-Premise

12. Artificial Intelligence in Healthcare Market, by End-User

  • 12.1. Academic & Research Institutions
  • 12.2. Diagnostic Centers
  • 12.3. Hospitals & Healthcare Providers
  • 12.4. Pharmaceutical & Biotechnology Companies

13. Artificial Intelligence in Healthcare Market, by Region

  • 13.1. Asia-Pacific
  • 13.2. North America
  • 13.3. Latin America
  • 13.4. Europe
  • 13.5. Middle East
  • 13.6. Africa

14. Artificial Intelligence in Healthcare Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Artificial Intelligence in Healthcare Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. Competitive Landscape

  • 16.1. Market Concentration Analysis, 2025
    • 16.1.1. Concentration Ratio (CR)
    • 16.1.2. Herfindahl Hirschman Index (HHI)
  • 16.2. Recent Developments & Impact Analysis, 2025
  • 16.3. Product Portfolio Analysis, 2025
  • 16.4. Benchmarking Analysis, 2025

17. Company Profiles

  • 17.1. AiCure, LLC
  • 17.2. Aidoc Medical Ltd.
  • 17.3. Amazon Web Services, Inc.
  • 17.4. Atomwise Inc.
  • 17.5. Behold.ai Technologies Limited
  • 17.6. BenevolentAI Limited
  • 17.7. BPGbio, Inc.
  • 17.8. Butterfly Network, Inc.
  • 17.9. CANON MEDICAL SYSTEMS CORPORATION
  • 17.10. ClosedLoop.ai Inc.
  • 17.11. Cognizant Technology Solutions Corporation
  • 17.12. ConcertAI by SymphonyAI LLC
  • 17.13. eMed Healthcare UK Limited
  • 17.14. Epic Systems Corporation
  • 17.15. Flatiron Health, Inc. by F. Hoffmann-La Roche Ltd.
  • 17.16. GE Healthcare
  • 17.17. Google, LLC by Alphabet, Inc.
  • 17.18. Health Catalyst, Inc.
  • 17.19. Intel Corporation
  • 17.20. International Business Machines Corporation
  • 17.21. IQVIA Holdings Inc.
  • 17.22. Koninklijke Philips N.V.
  • 17.23. Medasense Biometrics Ltd.
  • 17.24. Medtronic plc
  • 17.25. Merative L.P.
  • 17.26. Microsoft Corporation
  • 17.27. Modernizing Medicine, Inc.
  • 17.28. Nano-X Imaging Ltd.
  • 17.29. Novo Nordisk A/S
  • 17.30. NVIDIA Corporation
  • 17.31. Oncora Medical
  • 17.32. Oracle Corporation
  • 17.33. Oxipit
  • 17.34. Palantir Technologies Inc.
  • 17.35. Recursion Pharmaceuticals, Inc.
  • 17.36. Salesforce, Inc.
  • 17.37. Sanofi SA
  • 17.38. SAS Institute Inc.
  • 17.39. Sensely, Inc. by Mediktor
  • 17.40. Siemens Healthineers AG
  • 17.41. Tempus Labs, Inc.
  • 17.42. UnitedHealth Group

LIST OF FIGURES

  • FIGURE 1. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, YEARS CONSIDERED FOR THE STUDY
  • FIGURE 2. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, RESEARCH DESIGN
  • FIGURE 3. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, RESEARCH FRAMEWORK
  • FIGURE 4. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, DATA TRIANGULATION
  • FIGURE 5. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 6. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 7. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 8. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY TYPE, 2025 VS 2032 (%)
  • FIGURE 9. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY DELIVERY CHANNEL, 2025 VS 2032 (%)
  • FIGURE 11. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY DELIVERY CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY DISEASE CATEGORY, 2025 VS 2032 (%)
  • FIGURE 13. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY DISEASE CATEGORY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 14. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY APPLICATION, 2025 VS 2032 (%)
  • FIGURE 15. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 16. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY DEPLOYMENT MODE, 2025 VS 2032 (%)
  • FIGURE 17. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY DEPLOYMENT MODE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 18. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY END-USER, 2025 VS 2032 (%)
  • FIGURE 19. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY END-USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 20. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY REGION, 2025 VS 2032 (%)
  • FIGURE 21. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 22. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
  • FIGURE 23. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 24. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
  • FIGURE 25. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL HARDWARE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL HARDWARE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL HARDWARE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL MONITORING EQUIPMENT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL MONITORING EQUIPMENT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL MONITORING EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL ROBOTICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL ROBOTICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL ROBOTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL WEARABLE DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL WEARABLE DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL WEARABLE DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL SERVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL SERVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL CONSULTING SERVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL CONSULTING SERVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL CONSULTING SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL DEPLOYMENT & INTEGRATION SERVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL DEPLOYMENT & INTEGRATION SERVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL DEPLOYMENT & INTEGRATION SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL MAINTENANCE & SUPPORT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL MAINTENANCE & SUPPORT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL MAINTENANCE & SUPPORT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL SOFTWARE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL SOFTWARE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL SOFTWARE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL CLINICAL DECISION SUPPORT SYSTEMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL CLINICAL DECISION SUPPORT SYSTEMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL CLINICAL DECISION SUPPORT SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL DATA MANAGEMENT & ANALYSIS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL DATA MANAGEMENT & ANALYSIS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL DATA MANAGEMENT & ANALYSIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL DRUG DISCOVERY PLATFORMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL DRUG DISCOVERY PLATFORMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL DRUG DISCOVERY PLATFORMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL MEDICAL IMAGING PLATFORMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL MEDICAL IMAGING PLATFORMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL MEDICAL IMAGING PLATFORMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL NATURAL LANGUAGE PROCESSING APPLICATIONS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL NATURAL LANGUAGE PROCESSING APPLICATIONS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL NATURAL LANGUAGE PROCESSING APPLICATIONS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY DELIVERY CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL DIGITAL PLATFORMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL DIGITAL PLATFORMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL DIGITAL PLATFORMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL ONSITE SERVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL ONSITE SERVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL ONSITE SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL REMOTE SERVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL REMOTE SERVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL REMOTE SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY DISEASE CATEGORY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL CARDIOVASCULAR DISORDERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL CARDIOVASCULAR DISORDERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL CARDIOVASCULAR DISORDERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL DERMATOLOGICAL DISORDERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL DERMATOLOGICAL DISORDERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL DERMATOLOGICAL DISORDERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL GASTROINTESTINAL DISORDERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL GASTROINTESTINAL DISORDERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL GASTROINTESTINAL DISORDERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL NEUROLOGICAL DISORDERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL NEUROLOGICAL DISORDERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL NEUROLOGICAL DISORDERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL ONCOLOGY DISORDERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL ONCOLOGY DISORDERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL ONCOLOGY DISORDERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL ORTHOPEDIC DISORDERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL ORTHOPEDIC DISORDERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL ORTHOPEDIC DISORDERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL RESPIRATORY DISORDERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL RESPIRATORY DISORDERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL RESPIRATORY DISORDERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL ADMINISTRATIVE WORKFLOW MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL ADMINISTRATIVE WORKFLOW MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL ADMINISTRATIVE WORKFLOW MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL APPOINTMENT SCHEDULING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL APPOINTMENT SCHEDULING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL APPOINTMENT SCHEDULING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL BILLING MANAGEMENT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL BILLING MANAGEMENT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL BILLING MANAGEMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL COMPLIANCE MANAGEMENT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL COMPLIANCE MANAGEMENT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL COMPLIANCE MANAGEMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL RECORD MANAGEMENT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL RECORD MANAGEMENT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL RECORD MANAGEMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL DIAGNOSTICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL DIAGNOSTICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL CLINICAL TESTING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL CLINICAL TESTING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL CLINICAL TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL GENETIC TESTING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL GENETIC TESTING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL GENETIC TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL PATHOLOGY DIAGNOSTICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL PATHOLOGY DIAGNOSTICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL PATHOLOGY DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL RADIOLOGY DIAGNOSTICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL RADIOLOGY DIAGNOSTICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL RADIOLOGY DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL PATIENT MONITORING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 109. GLOBAL PATIENT MONITORING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 110. GLOBAL PATIENT MONITORING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 111. GLOBAL ICU MONITORING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 112. GLOBAL ICU MONITORING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 113. GLOBAL ICU MONITORING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 114. GLOBAL REMOTE PATIENT MONITORING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 115. GLOBAL REMOTE PATIENT MONITORING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 116. GLOBAL REMOTE PATIENT MONITORING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 117. GLOBAL VITAL SIGN MONITORING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 118. GLOBAL VITAL SIGN MONITORING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 119. GLOBAL VITAL SIGN MONITORING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 120. GLOBAL TREATMENT MANAGEMENT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 121. GLOBAL TREATMENT MANAGEMENT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 122. GLOBAL TREATMENT MANAGEMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 123. GLOBAL DRUG THERAPY OPTIMIZATION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 124. GLOBAL DRUG THERAPY OPTIMIZATION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 125. GLOBAL DRUG THERAPY OPTIMIZATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 126. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 127. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 128. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 129. GLOBAL RADIATION THERAPY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 130. GLOBAL RADIATION THERAPY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 131. GLOBAL RADIATION THERAPY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 132. GLOBAL ROBOTIC SURGERY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 133. GLOBAL ROBOTIC SURGERY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 134. GLOBAL ROBOTIC SURGERY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 135. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 136. GLOBAL CLOUD-BASED MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 137. GLOBAL CLOUD-BASED MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 138. GLOBAL CLOUD-BASED MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 139. GLOBAL HYBRID MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 140. GLOBAL HYBRID MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 141. GLOBAL HYBRID MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 142. GLOBAL ON-PREMISE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 143. GLOBAL ON-PREMISE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 144. GLOBAL ON-PREMISE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 145. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 146. GLOBAL ACADEMIC & RESEARCH INSTITUTIONS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 147. GLOBAL ACADEMIC & RESEARCH INSTITUTIONS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 148. GLOBAL ACADEMIC & RESEARCH INSTITUTIONS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 149. GLOBAL DIAGNOSTIC CENTERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 150. GLOBAL DIAGNOSTIC CENTERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 151. GLOBAL DIAGNOSTIC CENTERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 152. GLOBAL HOSPITALS & HEALTHCARE PROVIDERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 153. GLOBAL HOSPITALS & HEALTHCARE PROVIDERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 154. GLOBAL HOSPITALS & HEALTHCARE PROVIDERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 155. GLOBAL PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 156. GLOBAL PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 157. GLOBAL PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 158. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 159. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 160. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 161. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 162. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 163. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 164. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY DELIVERY CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 165. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY DISEASE CATEGORY, 2018-2032 (USD MILLION)
  • TABLE 166. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 167. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY ADMINISTRATIVE WORKFLOW, 2018-2032 (USD MILLION)
  • TABLE 168. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 169. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY PATIENT MONITORING, 2018-2032 (USD MILLION)
  • TABLE 170. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY TREATMENT MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 171. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 172. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 173. NORTH AMERICA ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 174. NORTH AMERICA ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 175. NORTH AMERICA ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 176. NORTH AMERICA ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 177. NORTH AMERICA ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 178. NORTH AMERICA ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY DELIVERY CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 179. NORTH AMERICA ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY DISEASE CATEGORY, 2018-2032 (USD MILLION)
  • TABLE 180. NORTH AMERICA ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 181. NORTH AMERICA ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY ADMINISTRATIVE WORKFLOW, 2018-2032 (USD MILLION)
  • TABLE 182. NORTH AMERICA ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 183. NORTH AMERICA ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY PATIENT MONITORING, 2018-2032 (USD MILLION)
  • TABLE 184. NORTH AMERICA ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY TREATMENT MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 185. NORTH AMERICA ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 186. NORTH AMERICA ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 187. LATIN AMERICA ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 188. LATIN AMERICA ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 189. LATIN AMERICA ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 190. LATIN AMERICA ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 191. LATIN AMERICA ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 192. LATIN AMERICA ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY DELIVERY CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 193. LATIN AMERICA ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY DISEASE CATEGORY, 2018-2032 (USD MILLION)
  • TABLE 194. LATIN AMERICA ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 195. LATIN AMERICA ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY ADMINISTRATIVE WORKFLOW, 2018-2032 (USD MILLION)
  • TABLE 196. LATIN AMERICA ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 197. LATIN AMERICA ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY PATIENT MONITORING, 2018-2032 (USD MILLION)
  • TABLE 198. LATIN AMERICA ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY TREATMENT MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 199. LATIN AMERICA ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 200. LATIN AMERICA ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 201. EUROPE ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 202. EUROPE ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 203. EUROPE ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 204. EUROPE ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 205. EUROPE ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 206. EUROPE ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY DELIVERY CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 207. EUROPE ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY DISEASE CATEGORY, 2018-2032 (USD MILLION)
  • TABLE 208. EUROPE ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 209. EUROPE ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY ADMINISTRATIVE WORKFLOW, 2018-2032 (USD MILLION)
  • TABLE 210. EUROPE ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 211. EUROPE ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY PATIENT MONITORING, 2018-2032 (USD MILLION)
  • TABLE 212. EUROPE ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY TREATMENT MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 213. EUROPE ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 214. EUROPE ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 215. MIDDLE EAST ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 216. MIDDLE EAST ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 217. MIDDLE EAST ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 218. MIDDLE EAST ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 219. MIDDLE EAST ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 220. MIDDLE EAST ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY DELIVERY CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 221. MIDDLE EAST ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY DISEASE CATEGORY, 2018-2032 (USD MILLION)
  • TABLE 222. MIDDLE EAST ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 223. MIDDLE EAST ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY ADMINISTRATIVE WORKFLOW, 2018-2032 (USD MILLION)
  • TABLE 224. MIDDLE EAST ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 225. MIDDLE EAST ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY PATIENT MONITORING, 2018-2032 (USD MILLION)
  • TABLE 226. MIDDLE EAST ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY TREATMENT MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 227. MIDDLE EAST ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 228. MIDDLE EAST ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 229. AFRICA ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 230. AFRICA ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 231. AFRICA ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 232. AFRICA ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 233. AFRICA ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 234. AFRICA ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY DELIVERY CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 235. AFRICA ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY DISEASE CATEGORY, 2018-2032 (USD MILLION)
  • TABLE 236. AFRICA ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 237. AFRICA ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY ADMINISTRATIVE WORKFLOW, 2018-2032 (USD MILLION)
  • TABLE 238. AFRICA ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 239. AFRICA ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY PATIENT MONITORING, 2018-2032 (USD MILLION)
  • TABLE 240. AFRICA ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY TREATMENT MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 241. AFRICA ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 242. AFRICA ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 243. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 244. ASEAN ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 245. ASEAN ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 246. ASEAN ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 247. ASEAN ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 248. ASEAN ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 249. ASEAN ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY DELIVERY CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 250. ASEAN ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY DISEASE CATEGORY, 2018-2032 (USD MILLION)
  • TABLE 251. ASEAN ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 252. ASEAN ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY ADMINISTRATIVE WORKFLOW, 2018-2032 (USD MILLION)
  • TABLE 253. ASEAN ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 254. ASEAN ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY PATIENT MONITORING, 2018-2032 (USD MILLION)
  • TABLE 255. ASEAN ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY TREATMENT MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 256. ASEAN ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 257. ASEAN ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 258. GCC ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 259. GCC ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 260. GCC ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 261. GCC ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 262. GCC ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 263. GCC ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY DELIVERY CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 264. GCC ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY DISEASE CATEGORY, 2018-2032 (USD MILLION)
  • TABLE 265. GCC ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 266. GCC ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY ADMINISTRATIVE WORKFLOW, 2018-2032 (USD MILLION)
  • TABLE 267. GCC ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 268. GCC ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY PATIENT MONITORING, 2018-2032 (USD MILLION)
  • TABLE 269. GCC ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY TREATMENT MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 270. GCC ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 271. GCC ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 272. EUROPEAN UNION ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 273. EUROPEAN UNION ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 274. EUROPEAN UNION ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 275. EUROPEAN UNION ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 276. EUROPEAN UNION ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 277. EUROPEAN UNION ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY DELIVERY CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 278. EUROPEAN UNION ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY DISEASE CATEGORY, 2018-2032 (USD MILLION)
  • TABLE 279. EUROPEAN UNION ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 280. EUROPEAN UNION ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY ADMINISTRATIVE WORKFLOW, 2018-2032 (USD MILLION)
  • TABLE 281. EUROPEAN UNION ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 282. EUROPEAN UNION ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY PATIENT MONITORING, 2018-2032 (USD MILLION)
  • TABLE 283. EUROPEAN UNION ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY TREATMENT MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 284. EUROPEAN UNION ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 285. EUROPEAN UNION ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 286. BRICS ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 287. BRICS ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 288. BRICS ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 289. BRICS ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 290. BRICS ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 291. BRICS ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY DELIVERY CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 292. BRICS ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY DISEASE CATEGORY, 2018-2032 (USD MILLION)
  • TABLE 293. BRICS ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 294. BRICS ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY ADMINISTRATIVE WORKFLOW, 2018-2032 (USD MILLION)
  • TABLE 295. BRICS ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 296. BRICS ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY PATIENT MONITORING, 2018-2032 (USD MILLION)
  • TABLE 297. BRICS ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY TREATMENT MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 298. BRICS ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 299. BRICS ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 300. G7 ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 301. G7 ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 302. G7 ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 303. G7 ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 304. G7 ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 305. G7 ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY DELIVERY CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 306. G7 ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY DISEASE CATEGORY, 2018-2032 (USD MILLION)
  • TABLE 307. G7 ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 308. G7 ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY ADMINISTRATIVE WORKFLOW, 2018-2032 (USD MILLION)
  • TABLE 309. G7 ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 310. G7 ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY PATIENT MONITORING, 2018-2032 (USD MILLION)
  • TABLE 311. G7 ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY TREATMENT MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 312. G7 ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 313. G7 ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 314. NATO ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 315. NATO ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 316. NATO ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 317. NATO ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 318. NATO ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 319. NATO ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY DELIVERY CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 320. NATO ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY DISEASE CATEGORY, 2018-2032 (USD MILLION)
  • TABLE 321. NATO ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 322. NATO ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY ADMINISTRATIVE WORKFLOW, 2018-2032 (USD MILLION)
  • TABLE 323. NATO ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 324. NATO ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY PATIENT MONITORING, 2018-2032 (USD MILLION)
  • TABLE 325. NATO ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY TREATMENT MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 326. NATO ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 327. NATO ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 328. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 329. UNITED STATES ARTIFICIAL INTELLIGENCE IN H